Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers
Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers. New York, USA – December 27, 2022 – Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the biotechnology industry, expanded its monoclonal antibodies capabilities and offerings to global customers, including over 1,000 of targets, carrier-free formulations, and conjugated […]
Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers Read More »
Media & Communications





